Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 171,017 | 182,898 | 146,552 | 105,853 | 113,596 |
| Marketable Securities | 203,210 | 238,104 | 275,664 | 309,812 | 313,486 |
| Receivables | N/A | N/A | 5,000 | 175 | 174 |
| TOTAL | $377,733 | $424,597 | $430,988 | $421,942 | $434,216 |
| Non-Current Assets | |||||
| PPE Net | 1,618 | 1,695 | 1,481 | 1,584 | 1,445 |
| Investments And Advances | 54,305 | 23,418 | 45,707 | 68,551 | 73,128 |
| Other Non-Current Assets | 1,541 | 1,795 | 1,973 | 2,149 | 208 |
| TOTAL | $57,464 | $26,908 | $49,161 | $72,284 | $74,781 |
| Total Assets | $435,197 | $451,505 | $480,149 | $494,226 | $508,997 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,237 | 10,522 | 10,921 | 9,072 | 5,443 |
| Accrued Expenses | 11,052 | 15,286 | 14,102 | 8,400 | 8,761 |
| Other current liabilities | 871 | 845 | 819 | 794 | 58 |
| TOTAL | $29,535 | $29,730 | $30,623 | $24,754 | $21,836 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 654 | 883 | 1,105 | 1,317 | 796 |
| TOTAL | $654 | $883 | $1,105 | $1,317 | $796 |
| Total Liabilities | $30,189 | $30,613 | $31,728 | $26,071 | $22,632 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,265 | 27,133 | 27,048 | 27,024 | 26,987 |
| Common Shares | 27 | 27 | 27 | 27 | 27 |
| Retained earnings | -244,026 | -223,763 | -192,730 | -168,768 | -146,690 |
| Other shareholders' equity | 338 | 480 | 574 | 204 | -223 |
| TOTAL | $405,008 | $420,892 | $448,421 | $468,155 | $486,365 |
| Total Liabilities And Equity | $435,197 | $451,505 | $480,149 | $494,226 | $508,997 |